Psychopharmacology Flashcards
(35 cards)
Explain antipsychotics
- First generation antipsychotics: FGAs (‘Typical antipsychotics’)
- Chlorpromazine, haloperidol, flupentixol, zuclopenthixol, sulpiride
- Second generation antipsychotics: SGAs (‘Atypical antipsychotics’)
- Olanzapine, quetiapine, risperidone, paliperidone, clozapine, aripiprazole, lurasidone, amisulpride
- Depot antipsychotics (Long Acting Injectable, LAI)
- Aripiprazole, flupentixol, zuclopenthixol, risperidone, paliperidone, olanzapine, haloperidol
- Note: not all antipsychotics are available as a depot formulation
- Aripiprazole, flupentixol, zuclopenthixol, risperidone, paliperidone, olanzapine, haloperidol
Explain antipsychotics MOA
What pathways do antipsychotics work on?
- Nigrostriatal (fine tuning)
- Mesolimbic → antipsychotic effect (EMOTION)
- Mesocortical → antipsychotic effect (personality???)
- Tuberoinfundibular system
Explain the MOA of 1st generation antipsychotics and their efficacy
- Therapeutic effect due to D2 receptor blockade in the meso-limbic and meso-cortical dopamine pathways
- Trials suggest that efficacy of FGAs is equivalent to that of SGAs
- Clozapine is the only antipsychotic to have demonstrated superior efficacy over other antipsychotics
- Side-effects can be problematic and can lead to poor adherence
What are the side effects of 1st generation antipsychotics?
- Blockade of D2 receptors in nigro-striatal area can cause extrapyramidal side effects
- Length of time to onset
- Within hours to days
- Acute dystonia (including oculogyric crisis)
- Akathisia
- Medium term
- Parkinsonism
- Long term
- Tardive dyskinesia
- Within hours to days
Manage acute dystonia and parkinsonism with Procyclidine (anticholinergic agent)
MORE
- D2 receptor antagonism at the tubero-infundibular pathway = hyperprolactinaemia
- Increase in prolactin levels (dopamine is inhibitory of prolactin release)
- Amenorrhoea, gynaecomastia, galactorrhoea, sexual dysfunction.
- Increase in prolactin levels (dopamine is inhibitory of prolactin release)
- Long term effects (regardless of the presence of symptoms) include a reduction in bone mineral density and an increase risk of breast cancer.
- Muscarinic effects
- Constipation, dry mouth, blurred vision, cognitive impairment
- Histaminergic effects
- Sedation
How to 2nd generation antipsychotics works and their efficacy
- Efficacy arising from D2 and 5HT2A receptor antagonism
- Wide spectrum of activity across a range of neurotransmitter receptor sites
What are the side effects of 2nd generation antipsychotics?
- Metabolic side-effects
- Weight gain
- Impaired glucose tolerance
- Dyslipidaemia
- Less likely to cause extrapyramidal side-effects than FGAs
- Aripiprazole and Lurasidone have less metabolic effects and arguably the best side-effect profile of any antipsychotics
Explain clozapine and the side effects and monitoring
- Licensed for ‘treatment-resistant schizophrenia’ as well as psychosis in Parkinson’s disease
- Side-effects:
- Profound sedation
- Hypersalivation
- Hypo/hypertension
- Fever
- Seizures
- Weight gain
- Myocarditis/Cardiomyopathy
- Neutropenia/agranulocytosis (1/10,000 mortality in the UK)
- Constipation
- Clozapine monitoring service – require regular FBC results for continuation of dispensing. Plasma level monitoring can guide dosing.
- Plasma level is affected by gender and tobacco smoking
Antipsychotics and ECG
- QTc prolongation may present as flutter, collapse or death
- Risk is compounded by additional meds that prolong the QT interval
- Antipsychotics
- Some antidepressants
- Antihistamines
- Lithium
- Methadone
- Erythromycin
- Grapefruit and liquorice consumption
- The risk between individual antipsychotics varies greatly – some have ‘no effect’ on the QT interval, some can prolong it by >20ms at therapeutic doses.
Explain neuroleptic malignant syndrome (NMS) (symptoms, blood tests, risk factors)
It is related to the level of dopamine blockade
Monitoring in antipsychotic medications
Baseline:
- Physical history, family history and examination
- Blood pressure and pulse
- Weight, height, BMI
- Bloods: fasting glucose/ HbA1C / fasting lipids / LFT / U&E / Prolactin
- ECG
Regularly monitoring is required thereafter with a full screen every 12 months as a minimum
Explain antidepressants
- First line:
- Selective serotonin reuptake inhibitors (SSRIs) (sertraline, fluoxetine, citalopram…)
- Other groups SNRIs, NASSAs…
- Tricyclics (TCAs) (Imipramine, clomipramine)
- Monoamine oxidase inhibitors (MAOIs) (Phenelzine or moclobemide)
NICE recommends an SSRI as first line option, no clear rationale for antidepressant choice thereafter but consider combined side effects, drug interactions, co-morbidities and risk of overdose.
List classes and examples of antidepressants
- TCAs: Lofepramine, Clomipramine, Amitriptyline, Imipramine
- SSRIs: Fluoxetine, Citalopram, Escitalopram, Sertraline, Paroxetine
- MAOIs: Phenelzine, Moclobemide
- SNRIs: Venlafaxine, Duloxetine
- NaSSAs: Mirtazapine
- NDRIs: Bupropion
- SARIs: Trazodone
- NARIs: Reboxetine
- Miscellaneous (e.g. Agomelatine, Vortioxetine, ECT, TMS, VNS, DBS)
What are the side effects of tricyclic antidepressants
- Histamine
- Sedation
- Muscarinic
- Dry mouth
- Constipation
- Blurred vision
- α-adrenoceptor
- Postural hypotension
What are the side effects of SSRIs?
- Very common (>10% incidence, the highest frequency category)
- Nausea
- Diarrhoea
- Headache
- Dry mouth
- Sexual Dysfunction (~60% incidence)
- All phases of sexual response (most common decreased libido & delayed orgasm)
What is a red flag that SSRIs can cause and explain who is at risk and symptoms
3 things
HYPONATRAEMIA
- Not dose related
- Usually presents within 30 days of initiation with the following symptoms:
- Headache, nausea, vomiting, cramps, lethargy, confusion
- Seizures, coma
- High risk groups
- Elderly
- Female
- Low body weight
- Hx of hyponatraemia
- Low baseline sodium
- Concomitant drugs which also cause hyponatraemia:
- Thiazide diuretics, NSAIDs, carbamazepine
- Reduced renal function
- Medical comorbidities (hypothyroidism, diabetes, COPD, CVA, cancers)
- Warm weather
INCREASED BLEEDING RISK
- Serotonin is released from platelets in response to injury →vasoconstriction and platelet aggregation.
- SSRIs inhibit this process.
- SSRI use associated with increased risk of
- Upper GI bleed (significant risk)
- Lower GI & uterine bleed.
- Blood loss in surgery.
- Caution
- If patients also take an NSAID, warfarin or steroids
- Peptic ulcer
- Very old age
- History of GI bleed
- Haemostatic defects e.g. cirrhosis
SUICIDALITY
- Antidepressant treatment linked with an increased risk of suicidal thoughts and acts during the first few weeks of treatment, particularly those <30 y/o
- All antidepressants implicated
- Absolute risk is very small
- Most effective way to prevent acts is to treat depression
- Toxicity in overdose
- Important counselling point – highlight this risk to the patients. Ask them to contact services if their feelings become unbearable
Findings in a patient with moderately severe serotonin syndrome
Explain antidepressant withdrawal
- NICE guidelines suggest that for some, withdrawal symptoms can be mild and resolve relatively quickly without the need for any help. Other people can have more severe symptoms which last much longer (sometimes months or more)
- Withdrawal symptoms include:
- Fluctuating anxiety levels
- Insomnia, agitation, low mood, anger, suicidal ideation
- Lability of mood
- Loss of co-ordination, dizziness
- Electric-shock like sensation, sometimes described as “brain zaps”. Particularly common in SSRI withdrawal
- Derealisation
- Akathisia
How long should an antidepressant be prescribed for?
- Treat a single episode of depression until symptoms resolve
- Maintain treatment for 6-9 months after remission of symptoms to reduce the risk of relapse
- Increase the length if multiple previous episodes of depression (up to 2 years if there’s a history of significant functional impairment as a result of depression)
What should be mentioned in counselling for antidepressants?
- Relief of symptoms is a gradual process and is usually extended when antidepressants are used in the management of anxiety disorders (up to 12-16 weeks for full benefits to be shown)
- Do not expect an instant effect
- Discuss side-effects
- Drug interactions
- Discuss the importance of good compliance and the need to maintain treatment even after symptoms resolve
- Antidepressants are not addictive but can cause withdrawal effects, particularly if they are stopped suddenly – reiterate the importance of not suddenly discontinuing medications unless this has been authorised and discussed with a prescriber
How to manage generalised anxiety disorder?
-
Generalised anxiety disorder: offer an SSRI first line. Consider sertraline due to it being the most cost-effective option (note that this is an off-label use)
- Consider an alternative SSRI or an SNRI if ineffective
- Consider pregabalin is SSRI/SNRIs aren’t tolerated
How to manage social anxiety disorder?
- Social anxiety disorder: SSRI (sertraline or escitalopram) recommended first line.
How to manage PTSD?
PTSD:
- Avoid chronic use of benzodiazepines. Consider venlafaxine (SNRI) or an SSRI if the person has a preference for drug treatment. Consider antipsychotics (i.e. risperidone) if there are disabling symptoms and behaviours e.g. hyperarousal or psychotic symptoms and if symptoms have not responded to other drugs.
How to manage OCD and BDD?
OCD & BDD:
- Offer an SSRI if the disease is associated with functional impairment. NICE recommends either fluoxetine, fluvoxamine, paroxetine, sertraline or citalopram.